Pharma News
EmpowerPharm Finishes Phase II Trial on Potential CBD Treatment for Social Anxiety Disorder
The trial of a pharmaceutical-grade CBD for social anxiety disorder, which was the first of its kind to be approved by the FDA, is expected to receive top line results next month.
Source link
#EmpowerPharm #Finishes #Phase #Trial #Potential #CBD #Treatment #Social #Anxiety #Disorder